ArticleFrontiers in bioengineering and biotechnology2025
The evolution and significance of embolization efficiency index (EEI) during transcatheter hepatic arterial embolization procedure: a pilot study based on computational fluid dynamics.
Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To investigate the hemodynamic determinants of the embolization efficiency index (EEI) during transcatheter hepatic arterial embolization (TAE), with the goal of improving embolization protocols, optimizing therapeutic precision, and mitigating the risks of non-target embolization. Methods: Using computational fluid dynamics and patient-specific right hepatic artery geometry from cone-beam CT angiography, we evaluated the impact of inlet flow rate, target outlet pressure, and vascular hierarchy on EEI. Simulations in OpenFOAM solved Navier-Stokes equations under steady and pulsatile flow. Results: There was no correlation between inlet flow rate and EEI. Instead, EEI exhibited an inverse linear relationship with target pressure, declining until flow cessation at a certain pressure greater than 5000Pa. Proximity to the target outlet significantly enhanced EEI. Backflow phenomenon indicated inherent non-target embolization risks under pulsatile conditions. Conclusion: This proof-of-concept study suggests that, in this model, EEI is primarily influenced by outlet pressure and vascular anatomy, rather than inflow dynamics. These findings call into question the conventional emphasis on flow modulation, pointing to the potential value of pressure-aware strategies and superselective catheter placement near targets. Based on the analyzed case, the study offers quantitative thresholds and spatial EEI gradients that could help refine TAE precision and potentially reduce complications. With further validation, integrating such CFD-based EEI metrics into procedural planning may contribute to standardizing embolization protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.